OsmoPrep (Salix Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the OsmoPrep drug offered from Salix Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Salix Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM PHOSPHATE, DIBASIC ANHYDROUS
SUBSTANCE NAME: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-05-15
END MARKETING DATE: 0000-00-00


OsmoPrep HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOsmoPrep from Salix Pharmaceuticals, Inc.
LABELER NAME: Salix Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.102; .398(g/1; g/1)
START MARKETING DATE: 2006-05-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65649-701_6c2e9f26-da54-408a-9b2e-e687b1aebcb1
PRODUCT NDC: 65649-701
APPLICATION NUMBER: NDA021892

Other SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthSodium Phosphates
Fresenius Kabi USA, LLCSodium Phosphates
Hospira, Inc.Sodium Phosphates
Salix Pharmaceuticals, Inc.OsmoPrep